S. Galpin

1.5k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

S. Galpin is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, S. Galpin has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Virology and 10 papers in Epidemiology. Recurrent topics in S. Galpin's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (14 papers) and Hepatitis B Virus Studies (6 papers). S. Galpin is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (14 papers) and Hepatitis B Virus Studies (6 papers). S. Galpin collaborates with scholars based in United Kingdom, Kenya and United States. S. Galpin's co-authors include Derek Kinchington, K. E. B. PARKES, John H. Merrett, I. B. R. Duncan, Joseph A. Martin, Jane Craig, Gareth J. Thomas, John Kay, Peter J. Machin and John Mills and has published in prestigious journals such as Science, Gut and FEBS Letters.

In The Last Decade

S. Galpin

23 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Design of Peptide-Based HIV Proteinase Inhibitors

1990 726 citations Derek Kinchington, S. Galpin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Galpin United Kingdom	14	828	707	365	272	211	23	1.2k
John H. Merrett United Kingdom	8	684 0.8×	499 0.7×	429 1.2×	252 0.9×	293 1.4×	10	1.2k
Derek Kinchington United Kingdom	17	954 1.2×	726 1.0×	589 1.6×	307 1.1×	325 1.5×	41	1.5k
Alison J. Ritchie United Kingdom	9	597 0.7×	531 0.8×	416 1.1×	167 0.6×	232 1.1×	9	1.0k
J C Quintero United States	13	1.7k 2.0×	1.6k 2.2×	529 1.4×	280 1.0×	352 1.7×	19	2.3k
Mark F. Knigge United States	12	1.0k 1.2×	639 0.9×	323 0.9×	460 1.7×	263 1.2×	13	1.7k
Anne V. Broadhurst United Kingdom	6	591 0.7×	514 0.7×	302 0.8×	102 0.4×	216 1.0×	8	855
H.L. Robbins United States	8	1.1k 1.3×	1.1k 1.5×	527 1.4×	138 0.5×	83 0.4×	10	1.4k
Lori J. Gabryelski United States	12	1.8k 2.1×	1.6k 2.3×	718 2.0×	268 1.0×	464 2.2×	16	2.2k
George A. Freeman United States	16	1.1k 1.4×	809 1.1×	645 1.8×	409 1.5×	549 2.6×	26	2.0k
Lilia M. Babé United States	16	467 0.6×	445 0.6×	418 1.1×	132 0.5×	119 0.6×	25	964

Countries citing papers authored by S. Galpin

Since Specialization

Citations

This map shows the geographic impact of S. Galpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Galpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Galpin more than expected).

Fields of papers citing papers by S. Galpin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Galpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Galpin. The network helps show where S. Galpin may publish in the future.

Co-authorship network of co-authors of S. Galpin

This figure shows the co-authorship network connecting the top 25 collaborators of S. Galpin. A scholar is included among the top collaborators of S. Galpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Galpin. S. Galpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beddows, Simon, S. Galpin, Ayman Johargy, et al.. (2003). Performance of two commercially available sequence‐based HIV‐1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes. Journal of Medical Virology. 70(3). 337–342. 31 indexed citations

Frater, John, Koya Ariyoshi, Duncan Churchill, et al.. (2001). Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients. AIDS. 15(12). 1493–1502. 78 indexed citations

Clarke, John R., S. Galpin, Rebecca A. Russell, et al.. (2000). Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients. Journal of Medical Virology. 62(4). 445–449. 17 indexed citations

Churchill, Duncan, Alexander S. Pym, S. Galpin, et al.. (1999). The Rabbit Study: Ritonavir and Saquinavir in Combination in Saquinavir-Experienced and Previously Untreated Patients. AIDS Research and Human Retroviruses. 15(13). 1181–1189. 5 indexed citations

Balfe, Peter, Michelle A. Penny, Philippa Easterbrook, et al.. (1998). Association between a Defective CCR-5 Gene and Progression to Disease in HIV Infection. AIDS Research and Human Retroviruses. 14(14). 1229–1234. 8 indexed citations

Jacobsen, Helmut, S. Galpin, Lucy Dorrell, et al.. (1997). Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir. Journal of Antimicrobial Chemotherapy. 39(6). 771–779. 27 indexed citations

Galpin, S., N. A. Roberts, Tim O’Connor, David Jeffries, & Derek Kinchington. (1994). Antiviral Properties of the HIV-1 Proteinase Inhibitor RO 31-8959. Antiviral chemistry & chemotherapy. 5(1). 43–45. 13 indexed citations

McGuigan, Christopher, et al.. (1993). Nucleoside analogues previously found to be inactive against HIV may be activated by simple chemical phosphorylation. FEBS Letters. 322(3). 249–252. 21 indexed citations

McGuigan, Christopher, et al.. (1993). 28 Kinase bypass: A new strategy for antl-HIV drug design. Antiviral Research. 20. 55–55. 9 indexed citations

10.

Kinchington, Derek, et al.. (1992). Temperature enhancement of syncytium formation by HIV and sendai virus. Journal of Medical Virology. 36(1). 44–48. 5 indexed citations

11.

Kinchington, Derek, S. Galpin, Jerzy W. Jaroszewski, et al.. (1992). A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1. Antiviral Research. 17(1). 53–62. 45 indexed citations

12.

Galpin, S., et al.. (1991). Further studies on the HIV proteinase inhibitor RO 31-8959. Antiviral Research. 15. 96–96. 1 indexed citations

13.

Apostolov, K., W. R. Barker, S. Galpin, et al.. (1989). Syncytia formation in HIV‐1 infected cells is associated with an increase in cellular oleic acid. FEBS Letters. 250(2). 241–244. 16 indexed citations

14.

Kinchington, Derek, et al.. (1989). Comparison of antigen capture assays against HIV-1 in evaluating antiviral compounds. AIDS. 3(2). 101–104. 30 indexed citations

15.

Karayiannis, Peter, et al.. (1986). Perinatal transmission of hepatitis B virus in Kenya: Its relation to the presence of serum HBV‐DNA and Anti‐HBe in the mother. Journal of Medical Virology. 19(2). 135–142. 21 indexed citations

16.

Waters, Jennifer A., Massimo Pignatelli, S. Galpin, Katsutoshi Ishihara, & Heath C. Thomas. (1986). Virus-neutralizing Antibodies to Hepatitis B Virus: The Nature of an Immunogenic Epitope on the S Gene Peptide. Journal of General Virology. 67(11). 2467–2473. 28 indexed citations

17.

Karayiannis, Peter, Alison H. Goodall, Jennifer A. Waters, et al.. (1985). Clinical evaluation of a monoclonal assay for hepatitis B surface antigen:Identification of “HBsAg‐like” polypeptides non‐reactive in conventional radioimmunoassays. Journal of Medical Virology. 15(3). 291–303. 2 indexed citations

18.

Weller, I V, Anna S. Lok, Adrian Mindel, et al.. (1985). Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.. Gut. 26(7). 745–751. 50 indexed citations

19.

Galpin, S., Peter Karayiannis, S. Middleton, & Howard C. Thomas. (1984). The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyte. Journal of Medical Virology. 14(3). 229–233. 5 indexed citations

20.

Karayiannis, Peter, et al.. (1984). Aetiology of acute sporadic hepatitis in adults in kenya. Journal of Medical Virology. 14(4). 357–362. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact